In this article

本文中

MRK

默克公司

TERN

三元网络路由器

Follow your favorite stocks

关注你喜爱的股票

CREATE FREE ACCOUNT

创建免费账户

Pharma giant

制药巨头

Merck

默克

is buying U.S. biotech firm

正在购买美国生物技术公司

Terns Pharmaceuticals

英文名：Terns Pharmaceuticals 中文名：TERN制药公司

for $6.7 billion, the company said Wednesday.

该公司周三表示，交易金额为67亿美元。

This is the third multibillion-dollar acquisition for Merck over the past year as the company looks to bulk up its portfolio ahead of its best-selling cancer drug Keytruda losing patent protection in 2028.

这是默克在过去一年中的第三次数十亿美元的收购，因为该公司希望在其最畅销的癌症药物Keytruda于2028年失去专利保护之前扩充其产品组合。

Terns shares rose 5.3% while Merck stock was largely flat in premarket trading.

云鹤股票上涨了5.3%，而默克股票在盘前交易中基本持平。

This is breaking news. Please refresh for updates.

这是突发新闻。请刷新以获取更新。

Choose CNBC as your preferred source on Google and never miss a moment from the most trusted name in business news.

将CNBC设置为Google上的首选来源，不错过商业新闻最值得信赖的名字的任何时刻。